Congenital hypogonadotropic hypogonadism with early-onset coronary artery disease

2Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The patient with congenital hypogonadotropic hypogonadism (HH) shows low serum levels of andro-gen, which is a group of sex hormones including testosterone, caused by the decreased gonadotropin release in the hypothalamus. Recent reports showed androgens exert protective effects against insulin resistance or ath-erosclerotic diseases, such as diabetes mellitus or coronary artery disease. However, whether the juvenile hypo-gonadism affects the diabetes or cardiovascular disease is unclear. We report a case of a middle-aged man with congenital HH who had severe coronary artery disease complicated with metabolic disorders. J. Med. Invest. 68: 189-191, February, 2021.

Cite

CITATION STYLE

APA

Takashima, A., Yagi, S., Yamaguchi, K., Kurahashi, K., Kojima, Y., Zheng, R., … Sata, M. (2021). Congenital hypogonadotropic hypogonadism with early-onset coronary artery disease. Journal of Medical Investigation, 68(1.2), 189–191. https://doi.org/10.2152/jmi.68.189

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free